Loading...

PFSA PROFUSA INC Company Mergers 8-K Filing

PRFS

PFS

PROFUSA INC

(PFSA)

2026 8-K

Note Modification Agreement

Asset Acquisition

Fundraising Update

Financial Agreement Update

Bitcoin Strategy Termination

License Agreement Signed

Reverse Stock Split

Stockholder Meeting Results

Securities Agreement Update

Financial Agreements Update

Quarterly Performance Update

Nasdaq Compliance Notice

Revenue Generation Plan

Share Increase Approved

Investor Presentation Update

Financing Update

Delisting Notice

Stockholder Meeting

Financing Agreement Update

Management Changes

Business Update

Merger of Equals

Merger of Equals

Merger of Equals

Merger of Equals

Merger of Equals

Changes in accounting/ audi...

Stockholder Meeting

Meeting Adjournment

Merger Amendment

Nasdaq Delisting

Nasdaq Compliance Issue

Nasdaq Compliance

Nasdaq Compliance Notice

Stockholder Meeting

Nasdaq Compliance Notice

Delisting - Non-Compliance ...

Annual Meeting of Stockholders

Merger Agreement

Merger Agreement

Amendment to Investment Man...

Special Meeting Approval

Merger Agreement

Stockholder Meeting Results

Supplement to Proxy Statement

External Links:

On April 21, 2026, Profusa, Inc. agreed to buy PanOmics Assay assets from Bio Insights LLC for $30 million, to be paid through newly created preferred stock, subject to stockholder approval.

AI Assistant

PROFUSA INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.